Munich - Delayed Quote EUR

CureVac NV (5CV.MU)

Get top stock picks
4.7520
-0.0020
(-0.04%)
As of 6:11:38 PM GMT+2. Market Open.
Get top stock picks
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
523,700
535,180
53,758
67,420
102,990
Cost of Revenue
65,015
105,829
124,366
183,993
238,195
Gross Profit
458,685
429,351
-70,608
-116,573
-135,205
Operating Expense
262,411
251,669
203,599
132,884
277,058
Operating Income
196,274
177,682
-274,207
-249,457
-412,263
Net Non Operating Interest Income Expense
11,998
12,357
15,448
-567
-235
Other Income Expense
--
842
-1,210
869
--
Pretax Income
209,113
190,881
-259,969
-249,155
-412,498
Tax Provision
28,458
28,695
198
-126
-782
Net Income Common Stockholders
180,655
162,186
-260,167
-249,029
-411,716
Diluted NI Available to Com Stockholders
180,655
162,186
-260,167
-249,029
-411,716
Basic EPS
0.80
0.72
-1.18
-1.32
-2.21
Diluted EPS
0.80
0.72
-1.18
-1.32
-2.21
Basic Average Shares
224,591.4780
224,376.8300
220,910.5090
189,074.9110
186,012.5860
Diluted Average Shares
225,485.1020
225,270.4540
220,910.5090
189,074.9110
186,012.5860
Total Operating Income as Reported
196,272
177,682
-274,207
-249,457
-412,263
Total Expenses
327,426
357,498
327,965
316,877
515,253
Net Income from Continuing & Discontinued Operation
180,655
162,186
-260,167
-249,029
-411,716
Normalized Income
179,927.5870
161,470.5772
-259,138.5000
-249,897.5605
-411,716
Interest Income
11,991
12,357
15,411
1,733
10,103
Interest Expense
-7
0
0
2,299
10,338
Net Interest Income
11,998
12,357
15,448
-567
-235
EBIT
209,106
190,881
-259,969
-246,856
-402,160
EBITDA
227,625
209,690
-236,583
-223,115
-386,486
Reconciled Cost of Revenue
54,258
94,834
114,801
171,612
231,502
Reconciled Depreciation
18,519
18,809
23,386
23,741
15,674
Net Income from Continuing Operation Net Minority Interest
180,655
162,186
-260,167
-249,029
-411,716
Total Unusual Items Excluding Goodwill
842
842
-1,210
869
0
Total Unusual Items
842
842
-1,210
869
0
Normalized EBITDA
226,783
208,848
-235,373
-223,984
-386,486
Tax Rate for Calcs
0.0001
0.0002
0.0002
0
0
Tax Effect of Unusual Items
114.5870
126.5772
-181.5000
0.4395
0
12/31/2021 - 8/14/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

22UA.HM BioNTech SE
91.85
-0.33%
 
EPIX ESSA Pharma Inc.
1.6800
+0.60%
 
4YL.BE Nanoform Finland PLC
1.0300
+19.77%
 
22UA.DE BioNTech SE
92.30
+0.71%
 
0QF.BE Moderna Inc
22.35
-2.85%
 
9IP1.F Rocket Pharmaceuticals, Inc.
2.3480
-5.82%
 
HLVX HilleVax, Inc.
1.8550
+0.27%
 
VVY.AS Vivoryon Therapeutics N.V.
1.6300
-0.73%
 
IKNA Ikena Oncology, Inc.
1.4300
+5.93%
 
1VT.BE Viking Therapeutics Inc
23.00
+1.70%